Reciprocal functional modulation of the activation of T lymphocytes and fibroblasts derived from human solid tumors

Journal of Immunology

Volumn 185, Issue 5, 2010, Pages 2681-2692

  Barnas, Jennifer L ^a   Simpson Abelson, Michelle R ^a   Brooks, Stephen P ^a   Kelleher Jr , Raymond J ^a   Bankert, Richard B ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CD3 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; IL17A PROTEIN, HUMAN;

ARTICLE; CANCER GROWTH; CARCINOGENESIS; CELL CONTACT; CELL INTERACTION; CELL TYPE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL CULTURE; HUMAN TISSUE; IMMUNOMODULATION; IMMUNOSTIMULATION; LUNG FIBROBLAST; LUNG NON SMALL CELL CANCER; LYMPHOCYTE FUNCTION; PRIORITY JOURNAL; SKIN FIBROBLAST; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH17 CELL; TUMOR MICROENVIRONMENT; BIOSYNTHESIS; CELL COMMUNICATION; CELL SEPARATION; COCULTURE; DOSE RESPONSE; FIBROBLAST; HELPER CELL; IMMUNOLOGY; LUNG TUMOR; LYMPHOCYTE ACTIVATION; METABOLISM; PATHOLOGY; T LYMPHOCYTE SUBPOPULATION; TUMOR CELL CULTURE;

CARCINOMA, NON-SMALL-CELL LUNG; CELL COMMUNICATION; CELL SEPARATION; COCULTURE TECHNIQUES; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; FIBROBLASTS; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-17; LUNG NEOPLASMS; LYMPHOCYTE ACTIVATION; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, HELPER-INDUCER; TH1 CELLS; TUMOR CELLS, CULTURED;

EID: 78049399458     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1000896     Document Type: Article

References (41)

1. Rabinovich, G. A., D. Gabrilovich, and E. M. Sotomayor. 2007. Immunosuppressive strategies that are mediated by tumor cells. Annu. Rev. Immunol. 25: 267-296.
2. Zou, W. 2005. Immunosuppressive networks in the tumour environment and their therapeutic relevance. Nat. Rev. Cancer 5: 263-274.
3. Gross, S., and P. Walden. 2008. Immunosuppressive mechanisms in human tumors: why we still cannot cure cancer. Immunol. Lett. 116: 7-14.
4. Laurent, G. J., R. C. Chambers, M. R. Hill, and R. J. McAnulty. 2007. Regulation of matrix turnover: fibroblasts, forces, factors and fibrosis. Biochem. Soc. Trans. 35: 647-651.
5. Silzle, T., G. J. Randolph, M. Kreutz, and L. A. Kunz-Schughart. 2004. The fibroblast: sentinel cell and local immune modulator in tumor tissue. Int. J. Cancer 108: 173-180.
6. Kalluri, R., and M. Zeisberg. 2006. Fibroblasts in cancer. Nat. Rev. Cancer 6: 392-401.
7. Baglole, C. J., D. M. Ray, S. H. Bernstein, S. E. Feldon, T. J. Smith, P. J. Sime, and R. P. Phipps. 2006. More than structural cells, fibroblasts create and orchestrate the tumor microenvironment. Immunol. Invest. 35: 297-325.
8. Buckley, C. D., D. Pilling, J. M. Lord, A. N. Akbar, D. Scheel-Toellner, and M. Salmon. 2001. Fibroblasts regulate the switch from acute resolving to chronic persistent inflammation. Trends Immunol. 22: 199-204.
9. Barnas, J., M. Simpson-Abelson, S. Yokota, R. Kelleher, and R. Bankert. 2010. T cells and stromal fibroblasts in human tumor microenvironments represent potential therapeutic targets. Cancer Microenvironment. DOI: 10.1007/s12307-010-0044-5. Available at: www.springer.com/biomed/cancer/journal/ 12307.
10. Nazareth, M. R., L. Broderick, M. R. Simpson-Abelson, R. J. Kelleher, Jr., S. J. Yokota, and R. B. Bankert. 2007. Characterization of human lung tumor-associated fibroblasts and their ability to modulate the activation of tumor-associated T cells. J. Immunol. 178: 5552-5562.
11. Erez, N., M. Truitt, P. Olson, and D. Hanahan. 2010. Cancer-associated fibroblasts are activated in incipient neoplasia to orchestrate tumor-promoting inflammation in an NF-kappaB-dependent manner. Cancer Cell 17: 135-147.
12. Nauta, A. J., and W. E. Fibbe. 2007. Immunomodulatory properties of mesenchymal stromal cells. Blood 110: 3499-3506.
13. Abeles, A. M., and M. H. Pillinger. 2006. The role of the synovial fibroblast in rheumatoid arthritis: cartilage destruction and the regulation of matrix metalloproteinases. Bull. NYU Hosp. Jt. Dis. 64: 20-24.
14. Bombara, M. P., D. L. Webb, P. Conrad, C. W. Marlor, T. Sarr, G. E. Ranges, T. M. Aune, J. M. Greve, and M. L. Blue. 1993. Cell contact between T cells and synovial fibroblasts causes induction of adhesion molecules and cytokines. J. Leukoc. Biol. 54: 399-406.
15. Wallace, P. K., T. Keler, K. Coleman, J. Fisher, L. Vitale, R. F. Graziano, P. M. Guyre, and M. W. Fanger. 1997. Humanized mAb H22 binds the human high affinity Fc receptor for IgG (FcgammaRI), blocks phagocytosis, and modulates receptor expression. J. Leukoc. Biol. 62: 469-479.
16. Broderick, L., S. J. Yokota, J. Reineke, E. Mathiowitz, C. C. Stewart, M. Barcos, R. J. Kelleher, Jr., and R. B. Bankert. 2005. Human CD4+ effector memory T cells persisting in the microenvironment of lung cancer xenografts are activated by local delivery of IL-12 to proliferate, produce IFN-gamma, and eradicate tumor cells. J. Immunol. 174: 898-906.
17. Manel, N., D. Unutmaz, and D. R. Littman. 2008. The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat. Nat. Immunol. 9: 641-649.
18. Chen, Z., and J. J. O'Shea. 2008. Regulation of IL-17 production in human lymphocytes. Cytokine 41: 71-78.
19. Boon, T., P. G. Coulie, B. J. Van den Eynde, and P. van der Bruggen. 2006. Human T cell responses against melanoma. Annu. Rev. Immunol. 24: 175-208.
20. Kryczek, I., S. Wei, L. Zou, S. Altuwaijri, W. Szeliga, J. Kolls, A. Chang, and W. Zou. 2007. Cutting edge: Th17 and regulatory T cell dynamics and the regulation by IL-2 in the tumor microenvironment. J. Immunol. 178: 6730-6733.
21. Miyahara, Y., K. Odunsi, W. Chen, G. Peng, J. Matsuzaki, and R. F. Wang. 2008. Generation and regulation of human CD4+ IL-17-producing T cells in ovarian cancer. Proc. Natl. Acad. Sci. USA 105: 15505-15510.
22. Murugaiyan, G., and B. Saha. 2009. Protumor vs antitumor functions of IL-17. J. Immunol. 183: 4169-4175.
23. Wang, L., T. Yi, M. Kortylewski, D. M. Pardoll, D. Zeng, and H. Yu. 2009. IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway. J. Exp. Med. 206: 1457-1464.
24. Haniffa, M. A., X. N. Wang, U. Holtick, M. Rae, J. D. Isaacs, A. M. Dickinson, C. M. Hilkens, and M. P. Collin. 2007. Adult human fibroblasts are potent immunoregulatory cells and functionally equivalent to mesenchymal stem cells. J. Immunol. 179: 1595-1604.
25. Le Blanc, K., L. Tammik, B. Sundberg, S. E. Haynesworth, and O. Ringdén. 2003. Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand. J. Immunol. 57: 11-20.
26. Glennie, S., I. Soeiro, P. J. Dyson, E. W. Lam, and F. Dazzi. 2005. Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells. Blood 105: 2821-2827.
27. Bartholomew, A., C. Sturgeon, M. Siatskas, K. Ferrer, K. McIntosh, S. Patil, W. Hardy, S. Devine, D. Ucker, R. Deans, et al. 2002. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp. Hematol. 30: 42-48.
28. Acosta-Rodriguez, E. V., G. Napolitani, A. Lanzavecchia, and F. Sallusto. 2007. Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat. Immunol. 8: 942-949.
29. Zhou, L., I. I. Ivanov, R. Spolski, R. Min, K. Shenderov, T. Egawa, D. E. Levy, W. J. Leonard, and D. R. Littman. 2007. IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat. Immunol. 8: 967-974.
30. Fossiez, F., O. Djossou, P. Chomarat, L. Flores-Romo, S. Ait-Yahia, C. Maat, J. J. Pin, P. Garrone, E. Garcia, S. Saeland, et al. 1996. T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J. Exp. Med. 183: 2593-2603.
31. Hwang, S. Y., J. Y. Kim, K. W. Kim, M. K. Park, Y. Moon, W. U. Kim, and H. Y. Kim. 2004. IL-17 induces production of IL-6 and IL-8 in rheumatoid arthritis synovial fibroblasts via NF-kappaB- and PI3-kinase/Akt-dependent pathways. Arthritis Res. Ther. 6: R120-R128.
32. Korn, T., M. Mitsdoerffer, A. L. Croxford, A. Awasthi, V. A. Dardalhon, G. Galileos, P. Vollmar, G. L. Stritesky, M. H. Kaplan, A. Waisman, et al. 2008. IL-6 controls Th17 immunity in vivo by inhibiting the conversion of conventional T cells into Foxp3+ regulatory T cells. Proc. Natl. Acad. Sci. USA 105: 18460-18465.
33. Samanta, A., B. Li, X. Song, K. Bembas, G. Zhang, M. Katsumata, S. J. Saouaf, Q. Wang, W. W. Hancock, Y. Shen, and M. I. Greene. 2008. TGF-beta and IL-6 signals modulate chromatin binding and promoter occupancy by acetylated FOXP3. Proc. Natl. Acad. Sci. USA 105: 14023-14027.
34. Wang, J., A. Ioan-Facsinay, E. I. van der Voort, T. W. Huizinga, and R. E. Toes. 2007. Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells. Eur. J. Immunol. 37: 129-138.
35. Allan, S. E., S. Q. Crome, N. K. Crellin, L. Passerini, T. S. Steiner, R. Bacchetta, M. G. Roncarolo, and M. K. Levings. 2007. Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production. Int. Immunol. 19: 345-354.
36. Ayroldi, E., O. Zollo, L. Cannarile, F. D' Adamio, U. Grohmann, D. V. Delfino, and C. Riccardi. 1998. Interleukin-6 (IL-6) prevents activation-induced cell death: IL-2-independent inhibition of Fas/fasL expression and cell death. Blood 92: 4212-4219.
37. Bauer, M., G. Su, C. Casper, R. He, W. Rehrauer, and A. Friedl. 2010. Heterogeneity of gene expression in stromal fibroblasts of human breast carcinomas and normal breast. Oncogene 29: 1732-1740.
38. Mueller, L., F. A. Goumas, M. Affeldt, S. Sandtner, U. M. Gehling, S. Brilloff, J. Walter, N. Karnatz, K. Lamszus, X. Rogiers, and D. C. Broering. 2007. Stromal fibroblasts in colorectal liver metastases originate from resident fibroblasts and generate an inflammatory microenvironment. Am. J. Pathol. 171: 1608-1618.
39. Pinchuk, I. V., J. I. Saada, E. J. Beswick, G. Boya, S. M. Qiu, R. C. Mifflin, G. S. Raju, V. E. Reyes, and D. W. Powell. 2008. PD-1 ligand expression by human colonic myofibroblasts/fibroblasts regulates CD4+ T-cell activity. Gastroenterology 135:1228-1237, 1237 e1-2.
40. Lee, S. K., S. H. Seo, B. S. Kim, C. D. Kim, J. H. Lee, J. S. Kang, P. J. Maeng, and J. S. Lim. 2005. IFN-gamma regulates the expression of B7-H1 in dermal fibroblast cells. J. Dermatol. Sci. 40: 95-103.
41. Mueller, M. M., and N. E. Fusenig. 2004. Friends or foes - bipolar effects of the tumour stroma in cancer. Nat. Rev. Cancer 4: 839-849.